mainly due to: • Current Liability decreased by THB 29 million as a result of the decrease of trade and other payables from Goods Payments and accrued bonuses settlement. • Non-current Liabilities

liability of 6.29 percent and the quick ratio of 0.80 times, which increased from the end of year 2018, due to a decrease in inventory of 0.97 percent and decrease in current liability of 6.29 percent and the

Group’s current ratio as at September 30, 2019 was 1.51 times, an increase from the end of year 2018, due to an increase in current assets of 6.53 percent but there was an increase in current liability of

714 million, remaining by Baht 313 million. And repayment loan to GJ Steel Baht 94 million (At year ended, no outstanding debt with GJS) and it had reclassified from current liability to non-current

1.0 0.9 Trade receivable 16,579 4.7% 15,219 4.3% Net debt to EBITDA (times) 0.9 0.9 0.8 Inventories 2,372 0.7% 2,104 0.6% Net debt & lease liability & Spectrum license payable to EBITDA 2.1 2.3 2.2

of Thailand The Board of Directors meeting of KGI Securities (Thailand) Plc (“the Company”), No.1/2019, held on 20th February 2019, approved the audited financial statements, including the consolidated

Exchange of Thailand The Board of Directors meeting of KGI Securities (Thailand) Plc (“the Company”), No.1/2020, held on 19th February 2020, approved the audited financial statements, including the

the year ended December 31, 2019 To Director and Manager the Stock Exchange of Thailand According to the Board of Directors’ Meeting No.2/ 2 0 2 0 of DOD Biotech Public Company Limited ( “ the Company

Company Limited (JSP) held the Board of Directors’ meeting no. 8/2560 on July 3, 2017, approved the Company to receive financial assistance from connected persons is as follows :- 1. Date of entering into

the risk of incomes. 8. Opinion of the board of directors on entering into transaction: The board of directors’ meeting of the Company unanimously resolved to approve the entering into the transaction